GlassScriptPhysician profile
Forrest B Swann
NPI 1407291420
$111,090.61
in general payments reported to CMS, 2019-2025
41 companies · $14K in 2025
The $14K reported for 2025 was more than what 94% of Cornea and External Diseases Specialist providers received nationally (typical 2025 total: $477).
See the full distribution for Cornea and External Diseases Specialist
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,583 · 2020: $17K · 2021: $21K · 2022: $24K · 2023: $8,695 · 2024: $21K · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $21K · Food and Beverage: $12K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $7,625 · Travel and Lodging: $3,028 · Honoraria: $1,001.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $20,750.00 |
| Food and Beverage | $11,989.87 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $7,625.00 |
| Travel and Lodging | $3,027.97 |
| Honoraria | $1,000.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ocular Therapeutix, INC. | $41,278.54 | 2019-2025 | Dextenza |
| Bausch & Lomb Americas INC. | $30,847.66 | 2022-2025 | Envista Mx60 Iol, Stellaris Elite, Crystalens Accommodating Iol (At-52ao) |
| Johnson & Johnson Surgical Vision, INC. | $8,989.39 | 2019-2025 | Tecnis Simplicity, Tecnis Iol, Veritas Vision System |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $8,818.65 | 2019-2021 | |
| Carl Zeiss Meditec, INC. | $4,482.27 | 2019-2023 | Artevo 800, Lumera 700 |
| Lensar, INC. | $2,774.67 | 2019-2025 | Lensar Laser System |
| Biotissue Holdings INC. | $1,933.84 | 2020-2025 | |
| Alcon Vision LLC | $1,606.22 | 2019-2025 | Argos, Ngenuity, Hydrus Microstent |
| Allergan, INC. | $1,431.88 | 2019-2022 | |
| Rxsight INC | $1,407.45 | 2021-2025 | Rxsight Contact Lens, Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Glaukos Corporation | $1,382.20 | 2019-2024 | Idose |
| Sight Sciences, INC. | $1,330.70 | 2019-2025 | Omni Surgical System, Sion Surgical Instrument |
| Abbvie INC. | $1,136.06 | 2022-2025 | Durysta, Lumigan, Vuity |
| Beaver-Visitec International, INC. | $380.55 | 2023 | |
| Lumibird Medical INC. | $340.32 | 2025 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $330.64 | 2024-2025 | Tepezza |
| New World Medical,INC. | $295.81 | 2020-2023 | |
| Tarsus Pharmaceuticals, INC. | $295.37 | 2024-2025 | Xdemvy |
| Carl Zeiss Meditec USA, INC. | $280.13 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $233.26 | 2019-2023 | |
| Sun Pharmaceutical Industries INC. | $197.08 | 2020-2023 | Xelpros, Cequa, Bromsite |
| Horizon Therapeutics Plc | $173.85 | 2022-2023 | Tepezza |
| Astellas Pharma US INC | $124.40 | 2024 | Izervay |
| Alcon Research LLC | $120.67 | 2020 | |
| Dompe US, INC. | $120.65 | 2019-2025 | Oxervate |
| Ivantis, INC | $115.49 | 2021 | |
| Tearlab Corp | $113.45 | 2023-2024 | Tearlab Osmolarity System, Scoutpro Osmolarity System |
| Ellexiscience | $102.95 | 2019 | |
| Bausch Health US, LLC | $102.44 | 2020 | |
| Thea Pharma INC. | $39.93 | 2023-2025 | Iyuzeh |
| Oyster Point Pharma, INC. | $38.59 | 2024-2025 | Tyrvaya, Ryzumvi |
| Eyevance Pharmaceuticals LLC | $37.47 | 2022-2023 | Flarex |
| Shire North American Group INC | $34.15 | 2019 | |
| Kala Pharmaceuticals, INC. | $33.32 | 2021-2022 | |
| Cormedix INC. | $27.85 | 2025 | Defencath |
| Mallinckrodt Hospital Products INC. | $26.57 | 2022 | |
| Staar Surgical Company | $26.26 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.60 | 2025 | |
| Mallinckrodt Enterprises LLC | $23.07 | 2019 | |
| Santen INC. | $20.90 | 2023 | Verkazia |
| Aerie Pharmaceuticals, INC. | $12.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Forrest Swann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.